Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
WHO Official Predicts Dire Future for Antibiotic Effectiveness
Speaking to a group of infectious disease experts in Copenhagen, the World Health Organization's (WHO) director general, Margaret Chan, warned that worldwide resistance to antibiotics is rising, to the point that common illnesses and injuries may once again become lethal. While it has long been known that bacteria, like other living things, develop resistance over time to those substances that threaten their survival, it is becoming more apparent that the popularity of antibiotics has accelerated this process in bacteria that infect humans. Pharmaceutical companies push antibiotics on the public and medical professionals, seeing them as money-makers. Patients demand them. Doctors are known to prescribe them even when unsure if a bacterial infection is present, “Just to be safe.” Patients often fail to take the full course of antibiotic treatment, leaving drug-resistant bacteria in their systems. And livestock treated with antibiotics are consumed by humans, who then ingest pathogens that have developed drug resistance when they eat a pork chop or hamburger. In a WHO release announcing the publication of a new book on the subject, “The Evolving Threat of Antimicrobial Resistance ' Options for Action,” Dr. Cho stated, “In terms of new replacement antibiotics, the pipeline is virtually dry. But much can be done. This includes prescribing antibiotics appropriately and only when needed, following treatment correctly, restricting the use of antibiotics in food production to therapeutic purposes and tackling the problem of substandard and counterfeit medicines.” See www.who.int/mediacentre/news/notes/2012/amr_20120308/en/index.html
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.